{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T21:50:31Z","timestamp":1794433831827,"version":"4.9.1"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T00:00:00Z","timestamp":1762128000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T00:00:00Z","timestamp":1762128000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-64674-7","type":"journal-article","created":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T13:05:11Z","timestamp":1762175111000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["SARS-CoV-2 NSP14 inhibitor exhibits potent antiviral activity and reverses NSP14-driven host modulation"],"prefix":"10.1038","volume":"16","author":[{"given":"Mengxin","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziqiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huimin","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kexin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liteng","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linjie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongkang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weihao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bizhi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingwei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-8423-4150","authenticated-orcid":false,"given":"Yichen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinxin","family":"Che","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2941-4808","authenticated-orcid":false,"given":"Rong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2178-4372","authenticated-orcid":false,"given":"Xiaowu","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4550-6211","authenticated-orcid":false,"given":"Wei","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,3]]},"reference":[{"key":"64674_CR1","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1038\/s41586-021-04188-6","volume":"600","author":"J Li","year":"2021","unstructured":"Li, J., Lai, S., Gao, G. F. & Shi, W. The emergence, genomic diversity and global spread of SARS-CoV-2. Nature 600, 408\u2013418 (2021).","journal-title":"Nature"},{"key":"64674_CR2","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/d41586-021-00396-2","volume":"590","author":"N Phillips","year":"2021","unstructured":"Phillips, N. The coronavirus is here to stay - here\u2019s what that means. Nature 590, 382\u2013384 (2021).","journal-title":"Nature"},{"key":"64674_CR3","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/s41573-023-00672-y","volume":"22","author":"G Li","year":"2023","unstructured":"Li, G., Hilgenfeld, R., Whitley, R. & De Clercq, E. Therapeutic strategies for COVID-19: progress and lessons learned. Nat. Rev. Drug Discov. 22, 449\u2013475 (2023).","journal-title":"Nat. Rev. Drug Discov."},{"key":"64674_CR4","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1021\/acscentsci.3c00538","volume":"9","author":"Y Hu","year":"2023","unstructured":"Hu, Y. et al. Naturally occurring mutations of SARS-CoV-2 main protease confer drug resistance to nirmatrelvir. ACS Cent. Sci. 9, 1658\u20131669 (2023).","journal-title":"ACS Cent. Sci."},{"key":"64674_CR5","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/s41586-022-05514-2","volume":"613","author":"S Iketani","year":"2023","unstructured":"Iketani, S. et al. Multiple pathways for SARS-CoV-2 resistance to nirmatrelvir. Nature 613, 558\u2013564 (2023).","journal-title":"Nature"},{"key":"64674_CR6","first-page":"793","volume":"609","author":"GJ Park","year":"2022","unstructured":"Park, G. J. et al. The mechanism of RNA capping by SARS-CoV-2. Nature 609, 793\u2013800 (2022).","journal-title":"Nature"},{"key":"64674_CR7","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/nrmicro2675","volume":"10","author":"E Decroly","year":"2011","unstructured":"Decroly, E., Ferron, F., Lescar, J. & Canard, B. Conventional and unconventional mechanisms for capping viral mRNA. Nat. Rev. Microbiol. 10, 51\u201365 (2011).","journal-title":"Nat. Rev. Microbiol."},{"key":"64674_CR8","doi-asserted-by":"crossref","unstructured":"Hsu, J. C.-C., Laurent-Rolle, M., Pawlak, J. B., Wilen, C. B. & Cresswell, P. Translational shutdown and evasion of the innate immune response by SARS-CoV-2 NSP14 protein. Proc. Natl. Acad. Sci. USA. 118, e2101161118 (2021).","DOI":"10.1073\/pnas.2101161118"},{"key":"64674_CR9","first-page":"178","volume":"21","author":"JM Minkoff","year":"2023","unstructured":"Minkoff, J. M. & tenOever, B. Innate immune evasion strategies of SARS-CoV-2. Nat. Rev. Microbiol. 21, 178\u2013194 (2023).","journal-title":"Nat. Rev. Microbiol."},{"key":"64674_CR10","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.03662-21","volume":"13","author":"R Pan","year":"2022","unstructured":"Pan, R. et al. N7-methylation of the coronavirus rna cap is required for maximal virulence by preventing innate immune recognition. mBio 13, e0366221 (2022).","journal-title":"mBio"},{"key":"64674_CR11","doi-asserted-by":"publisher","first-page":"4258","DOI":"10.1002\/jmv.27009","volume":"93","author":"M Tahir","year":"2021","unstructured":"Tahir, M. Coronavirus genomic nsp14-ExoN, structure, role, mechanism, and potential application as a drug target. J. Med. Virol. 93, 4258\u20134264 (2021).","journal-title":"J. Med. Virol."},{"key":"64674_CR12","doi-asserted-by":"publisher","first-page":"9372","DOI":"10.1073\/pnas.1201130109","volume":"109","author":"M Bouvet","year":"2012","unstructured":"Bouvet, M. et al. RNA 3\u2019-end mismatch excision by the severe acute respiratory syndrome coronavirus nonstructural protein nsp10\/nsp14 exoribonuclease complex. Proc. Natl Acad. Sci. 109, 9372\u20139377 (2012).","journal-title":"Proc. Natl Acad. Sci."},{"key":"64674_CR13","doi-asserted-by":"publisher","first-page":"3484","DOI":"10.1073\/pnas.0808790106","volume":"106","author":"Y Chen","year":"2009","unstructured":"Chen, Y. et al. Functional screen reveals SARS coronavirus nonstructural protein nsp14 as a novel cap N7 methyltransferase. Proc. Natl Acad. Sci. Usa. 106, 3484\u20133489 (2009).","journal-title":"Proc. Natl Acad. Sci. Usa."},{"key":"64674_CR14","doi-asserted-by":"publisher","first-page":"9436","DOI":"10.1073\/pnas.1508686112","volume":"112","author":"Y Ma","year":"2015","unstructured":"Ma, Y. et al. Structural basis and functional analysis of the SARS coronavirus nsp14-nsp10 complex. Proc. Natl Acad. Sci. Usa. 112, 9436\u20139441 (2015).","journal-title":"Proc. Natl Acad. Sci. Usa."},{"key":"64674_CR15","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.cell.2020.11.016","volume":"184","author":"L Yan","year":"2021","unstructured":"Yan, L. et al. Cryo-EM structure of an extended SARS-CoV-2 replication and transcription complex reveals an intermediate state in cap synthesis. Cell 184, 184\u2013193 (2021).","journal-title":"Cell"},{"key":"64674_CR16","doi-asserted-by":"publisher","first-page":"3474","DOI":"10.1016\/j.cell.2021.05.033","volume":"184","author":"L Yan","year":"2021","unstructured":"Yan, L. et al. Coupling of N7-methyltransferase and 3\u2032-5\u2032 exoribonuclease with SARS-CoV-2 polymerase reveals mechanisms for capping and proofreading. Cell 184, 3474\u20133485 (2021).","journal-title":"Cell"},{"key":"64674_CR17","doi-asserted-by":"publisher","first-page":"7248","DOI":"10.1128\/JVI.00542-16","volume":"90","author":"JB Case","year":"2016","unstructured":"Case, J. B., Ashbrook, A. W., Dermody, T. S. & Denison, M. R. Mutagenesis of S-adenosyl-l-methionine-binding residues in coronavirus nsp14 N7-methyltransferase demonstrates differing requirements for genome translation and resistance to innate immunity. J. Virol. 90, 7248\u20137256 (2016).","journal-title":"J. Virol."},{"key":"64674_CR18","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/JVI.01246-20","volume":"94","author":"NS Ogando","year":"2020","unstructured":"Ogando, N. S. et al. The enzymatic activity of the nsp14 exoribonuclease is critical for replication of MERS-CoV and SARS-CoV-2. J. Virol. 94, 10\u20131128 (2020).","journal-title":"J. Virol."},{"key":"64674_CR19","doi-asserted-by":"crossref","unstructured":"Ogando, N. S. et al. Structure-function analysis of the nsp14 N7-guanine methyltransferase reveals an essential role in Betacoronavirus replication. Proc. Natl. Acad. Sci. USA. 118, e2108709118 (2021).","DOI":"10.1073\/pnas.2108709118"},{"key":"64674_CR20","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.1042\/BCJ20210198","volume":"478","author":"B Canal","year":"2021","unstructured":"Canal, B. et al. Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp14\/nsp10 exoribonuclease. Biochem. J. 478, 2445\u20132464 (2021).","journal-title":"Biochem. J."},{"key":"64674_CR21","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1093\/nar\/gkab1279","volume":"50","author":"R Nencka","year":"2022","unstructured":"Nencka, R. et al. Coronaviral RNA-methyltransferases: function, structure and inhibition. Nucleic Acids Res 50, 635\u2013650 (2022).","journal-title":"Nucleic Acids Res"},{"key":"64674_CR22","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.antiviral.2012.07.007","volume":"96","author":"F Ferron","year":"2012","unstructured":"Ferron, F., Decroly, E., Selisko, B. & Canard, B. The viral RNA capping machinery as a target for antiviral drugs. Antivir. Res 96, 21\u201331 (2012).","journal-title":"Antivir. Res"},{"key":"64674_CR23","doi-asserted-by":"crossref","unstructured":"Zaffagni, M. et al. SARS-CoV-2 Nsp14 mediates the effects of viral infection on the host cell transcriptome. eLife 11, e71945 (2022).","DOI":"10.7554\/eLife.71945"},{"key":"64674_CR24","volume":"10","author":"E Zilecka","year":"2024","unstructured":"Zilecka, E. et al. Structure of SARS-CoV-2 MTase nsp14 with the inhibitor STM957 reveals inhibition mechanism that is shared with a poxviral MTase VP39. J. Struct. Biol. X 10, 100109 (2024).","journal-title":"J. Struct. Biol. X"},{"key":"64674_CR25","doi-asserted-by":"publisher","first-page":"4347","DOI":"10.1016\/j.cell.2022.09.037","volume":"185","author":"L Yan","year":"2022","unstructured":"Yan, L. et al. A mechanism for SARS-CoV-2 RNA capping and its inhibition by nucleotide analog inhibitors. Cell 185, 4347\u20134360.e17 (2022).","journal-title":"Cell"},{"key":"64674_CR26","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/s41579-021-00630-8","volume":"19","author":"H Yang","year":"2021","unstructured":"Yang, H. & Rao, Z. Structural biology of SARS-CoV-2 and implications for therapeutic development. Nat. Rev. Microbiol. 19, 685\u2013700 (2021).","journal-title":"Nat. Rev. Microbiol."},{"key":"64674_CR27","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1093\/nar\/gkac1207","volume":"51","author":"N Imprachim","year":"2023","unstructured":"Imprachim, N., Yosaatmadja, Y. & Newman, J. A. Crystal structures and fragment screening of SARS-CoV-2 NSP14 reveal details of exoribonuclease activation and mRNA capping and provide starting points for antiviral drug development. Nucleic Acids Res 51, 475\u2013487 (2023).","journal-title":"Nucleic Acids Res"},{"key":"64674_CR28","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41580-021-00432-z","volume":"23","author":"B Malone","year":"2022","unstructured":"Malone, B., Urakova, N., Snijder, E. J. & Campbell, E. A. Structures and functions of coronavirus replication-transcription complexes and their relevance for SARS-CoV-2 drug design. Nat. Rev. Mol. Cell Biol. 23, 21\u201339 (2022).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"64674_CR29","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1038\/s41594-022-00828-1","volume":"29","author":"J Kottur","year":"2022","unstructured":"Kottur, J., Rechkoblit, O., Quintana-Feliciano, R., Sciaky, D. & Aggarwal, A. K. High-resolution structures of the SARS-CoV-2 N7-methyltransferase inform therapeutic development. Nat. Struct. Mol. Biol. 29, 850\u2013853 (2022).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"64674_CR30","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1021\/acsmedchemlett.1c00140","volume":"12","author":"O Bobileva","year":"2021","unstructured":"Bobileva, O. et al. Potent SARS-CoV-2 mRNA cap methyltransferase inhibitors by bioisosteric replacement of methionine in SAM cosubstrate. ACS Med. Chem. Lett. 12, 1102\u20131107 (2021).","journal-title":"ACS Med. Chem. Lett."},{"key":"64674_CR31","doi-asserted-by":"publisher","first-page":"115474","DOI":"10.1016\/j.ejmech.2023.115474","volume":"256","author":"M Hausdorff","year":"2023","unstructured":"Hausdorff, M. et al. Structure-guided optimization of adenosine mimetics as selective and potent inhibitors of coronavirus nsp14 N7-methyltransferases. Eur. J. Med. Chem. 256, 115474 (2023).","journal-title":"Eur. J. Med. Chem."},{"key":"64674_CR32","doi-asserted-by":"publisher","first-page":"27410","DOI":"10.1021\/acsomega.3c02815","volume":"8","author":"M Stefek","year":"2023","unstructured":"Stefek, M. et al. Rational design of highly potent SARS-CoV-2 nsp14 methyltransferase inhibitors. ACS Omega 8, 27410\u201327418 (2023).","journal-title":"ACS Omega"},{"key":"64674_CR33","doi-asserted-by":"publisher","first-page":"3469","DOI":"10.1039\/D4MD00422A","volume":"15","author":"H Kocek","year":"2024","unstructured":"Kocek, H. et al. Discovery of highly potent SARS-CoV-2 nsp14 methyltransferase inhibitors based on adenosine 5\u2032-carboxamides. RSC Med. Chem. 15, 3469\u20133476 (2024).","journal-title":"RSC Med. Chem."},{"key":"64674_CR34","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1021\/acsmedchemlett.2c00265","volume":"13","author":"E Jung","year":"2022","unstructured":"Jung, E. et al. Bisubstrate inhibitors of severe acute respiratory syndrome coronavirus-2 nsp14 methyltransferase. ACS Med. Chem. Lett. 13, 1477\u20131484 (2022).","journal-title":"ACS Med. Chem. Lett."},{"key":"64674_CR35","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.1021\/acsinfecdis.1c00131","volume":"7","author":"T Otava","year":"2021","unstructured":"Otava, T. et al. The structure-based design of SARS-CoV-2 nsp14 methyltransferase ligands yields nanomolar inhibitors. ACS Infect. Dis. 7, 2214\u20132220 (2021).","journal-title":"ACS Infect. Dis."},{"key":"64674_CR36","doi-asserted-by":"publisher","first-page":"6231","DOI":"10.1021\/acs.jmedchem.2c00120","volume":"65","author":"R Ahmed-Belkacem","year":"2022","unstructured":"Ahmed-Belkacem, R. et al. Potent Inhibition of SARS-CoV-2 nsp14 N 7-Methyltransferase by Sulfonamide-Based Bisubstrate Analogues. J. Med. Chem. 65, 6231\u20136249 (2022).","journal-title":"J. Med. Chem."},{"key":"64674_CR37","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1177\/24725552211026261","volume":"26","author":"K Devkota","year":"2021","unstructured":"Devkota, K. et al. Probing the SAM binding site of SARS-CoV-2 Nsp14 in vitro using SAM competitive inhibitors guides developing selective bisubstrate inhibitors. SLAS Discov. Adv. Sci. Drug Discov. 26, 1200\u20131211 (2021).","journal-title":"SLAS Discov. Adv. Sci. Drug Discov."},{"key":"64674_CR38","doi-asserted-by":"publisher","first-page":"7582","DOI":"10.1039\/D2OB01569B","volume":"20","author":"R Amador","year":"2022","unstructured":"Amador, R. et al. Facile access to 4\u2032-(N-acylsulfonamide) modified nucleosides and evaluation of their inhibitory activity against SARS-CoV-2 RNA cap N 7-guanine-methyltransferase nsp14. Org. Biomol. Chem. 20, 7582\u20137586 (2022).","journal-title":"Org. Biomol. Chem."},{"key":"64674_CR39","doi-asserted-by":"crossref","unstructured":"Wen, Y. et al. Identification and Evaluation of Non-Nucleosidic MTase Inhibitors against SARS-CoV-2 nsp14 with Lower-Micromolar Anti-Coronavirus Activity. ACS Infect. Dis., (2025).","DOI":"10.1021\/acsinfecdis.4c01044"},{"key":"64674_CR40","doi-asserted-by":"publisher","first-page":"18642","DOI":"10.1021\/acs.jmedchem.4c01749","volume":"67","author":"X Li","year":"2024","unstructured":"Li, X. & Song, Y. Perspective for Drug Discovery Targeting SARS Coronavirus Methyltransferases: Function, Structure and Inhibition. J. Med. Chem. 67, 18642\u201318655 (2024).","journal-title":"J. Med. Chem."},{"key":"64674_CR41","doi-asserted-by":"publisher","first-page":"7785","DOI":"10.1021\/acs.jmedchem.2c02120","volume":"66","author":"I Singh","year":"2023","unstructured":"Singh, I. et al. Structure-Based Discovery of Inhibitors of the SARS-CoV-2 Nsp14 N7-Methyltransferase. J. Med. Chem. 66, 7785\u20137803 (2023).","journal-title":"J. Med. Chem."},{"key":"64674_CR42","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1042\/BCJ20210219","volume":"478","author":"S Basu","year":"2021","unstructured":"Basu, S. et al. Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of Nsp14 RNA cap methyltransferase. Biochem. J. 478, 2481\u20132497 (2021).","journal-title":"Biochem. J."},{"key":"64674_CR43","doi-asserted-by":"publisher","first-page":"105142","DOI":"10.1016\/j.antiviral.2021.105142","volume":"193","author":"R Kasprzyk","year":"2021","unstructured":"Kasprzyk, R. et al. Identification and evaluation of potential SARS-CoV-2 antiviral agents targeting mRNA cap guanine N7-Methyltransferase. Antivir. Res 193, 105142 (2021).","journal-title":"Antivir. Res"},{"key":"64674_CR44","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1038\/s41586-024-08320-0","volume":"637","author":"C Meyer","year":"2025","unstructured":"Meyer, C. et al. Small-molecule inhibition of SARS-CoV-2 NSP14 RNA cap methyltransferase. Nature 637, 1178\u20131185 (2025).","journal-title":"Nature"},{"key":"64674_CR45","doi-asserted-by":"crossref","unstructured":"Liao, Z. et al. DeepDock: enhancing ligand-protein interaction prediction by a combination of ligand and structure information. in 311\u2013317 (IEEE, 2019).","DOI":"10.1109\/BIBM47256.2019.8983365"},{"key":"64674_CR46","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/nrmicro.2016.81","volume":"14","author":"E De Wit","year":"2016","unstructured":"De Wit, E., Van Doremalen, N., Falzarano, D. & Munster, V. J. SARS and MERS: recent insights into emerging coronaviruses. Nat. Rev. Microbiol. 14, 523\u2013534 (2016).","journal-title":"Nat. Rev. Microbiol."},{"key":"64674_CR47","doi-asserted-by":"publisher","first-page":"861","DOI":"10.3390\/v14050861","volume":"14","author":"Y Chen","year":"2022","unstructured":"Chen, Y., Wang, X., Shi, H. & Zou, P. Montelukast inhibits HCoV-OC43 infection as a viral inactivator. Viruses 14, 861 (2022).","journal-title":"Viruses"},{"key":"64674_CR48","doi-asserted-by":"publisher","first-page":"14830","DOI":"10.18632\/oncotarget.14780","volume":"8","author":"H Zhou","year":"2017","unstructured":"Zhou, H. et al. The conformational changes of Zika virus methyltransferase upon converting SAM to SAH. Oncotarget 8, 14830 (2017).","journal-title":"Oncotarget"},{"key":"64674_CR49","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/s41586-021-03536-w","volume":"593","author":"E Yankova","year":"2021","unstructured":"Yankova, E. et al. Small-molecule inhibition of METTL3 as a strategy against myeloid leukaemia. Nature 593, 597\u2013601 (2021).","journal-title":"Nature"},{"key":"64674_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15424","volume":"8","author":"E San Jos\u00e9-En\u00e9riz","year":"2017","unstructured":"San Jos\u00e9-En\u00e9riz, E. et al. Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs in hematological malignancies. Nat. Commun. 8, 15424 (2017).","journal-title":"Nat. Commun."},{"key":"64674_CR51","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2023.2204164","volume":"12","author":"SK Samrat","year":"2023","unstructured":"Samrat, S. K. et al. A universal fluorescence polarization high throughput screening assay to target the SAM-binding sites of SARS-CoV-2 and other viral methyltransferases. Emerg. Microbes Infect. 12, 2204164 (2023).","journal-title":"Emerg. Microbes Infect."},{"key":"64674_CR52","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/s41418-021-00900-1","volume":"29","author":"G Rona","year":"2022","unstructured":"Rona, G. et al. The NSP14\/NSP10 RNA repair complex as a Pan-coronavirus therapeutic target. Cell Death Differ. 29, 285\u2013292 (2022).","journal-title":"Cell Death Differ."},{"key":"64674_CR53","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1021\/acschembio.5b00812","volume":"11","author":"J Zhang","year":"2016","unstructured":"Zhang, J. & Zheng, Y. G. SAM\/SAH analogs as versatile tools for SAM-dependent methyltransferases. ACS Chem. Biol. 11, 583\u2013597 (2016).","journal-title":"ACS Chem. Biol."},{"key":"64674_CR54","doi-asserted-by":"publisher","first-page":"6992","DOI":"10.1021\/jacs.4c00194","volume":"146","author":"L Xiong","year":"2024","unstructured":"Xiong, L. et al. Discovery of a Potent and Cell-Active Inhibitor of DNA 6mA Demethylase ALKBH1. J. Am. Chem. Soc. 146, 6992\u20137006 (2024).","journal-title":"J. Am. Chem. Soc."},{"key":"64674_CR55","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20542-0","volume":"12","author":"G Kokic","year":"2021","unstructured":"Kokic, G. et al. Mechanism of SARS-CoV-2 polymerase stalling by remdesivir. Nat. Commun. 12, 279 (2021).","journal-title":"Nat. Commun."},{"key":"64674_CR56","first-page":"994","volume":"383","author":"JH Beigel","year":"2020","unstructured":"Beigel, J. H., Tomashek, K. M. & Dodd, L. E. Remdesivir for the Treatment of Covid-19 - Preliminary Report. Reply. N. Engl. J. Med. 383, 994 (2020).","journal-title":"Reply. N. Engl. J. Med."},{"key":"64674_CR57","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adn9519","volume":"10","author":"H Wang","year":"2024","unstructured":"Wang, H. et al. Epitranscriptomic m5C methylation of SARS-CoV-2 RNA regulates viral replication and the virulence of progeny viruses in the new infection. Sci. Adv. 10, eadn9519 (2024).","journal-title":"Sci. Adv."},{"key":"64674_CR58","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1009439","volume":"17","author":"X Ju","year":"2021","unstructured":"Ju, X. et al. A novel cell culture system modeling the SARS-CoV-2 life cycle. PLoS Pathog. 17, e1009439 (2021).","journal-title":"PLoS Pathog."},{"key":"64674_CR59","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/s41421-023-00536-0","volume":"9","author":"B Yang","year":"2023","unstructured":"Yang, B. et al. A tissue specific-infection mouse model of SARS-CoV-2. Cell Discov. 9, 43 (2023).","journal-title":"Cell Discov."},{"key":"64674_CR60","doi-asserted-by":"crossref","unstructured":"Feng, F. et al. DAZAP2 functions as a pan-coronavirus restriction factor by inhibiting viral entry and genomic replication. bioRxiv 2025\u201302 e0038525 (2025).","DOI":"10.1101\/2025.02.04.636569"},{"key":"64674_CR61","doi-asserted-by":"publisher","first-page":"5399","DOI":"10.1128\/JVI.03259-15","volume":"90","author":"M Becares","year":"2016","unstructured":"Becares, M. et al. Mutagenesis of coronavirus nsp14 reveals its potential role in modulation of the innate immune response. J. Virol. 90, 5399\u20135414 (2016).","journal-title":"J. Virol."},{"key":"64674_CR62","doi-asserted-by":"publisher","first-page":"1007089","DOI":"10.3389\/fimmu.2022.1007089","volume":"13","author":"T-W Li","year":"2022","unstructured":"Li, T.-W. et al. SARS-CoV-2 Nsp14 protein associates with IMPDH2 and activates NF-\u03baB signaling. Front. Immunol. 13, 1007089 (2022).","journal-title":"Front. Immunol."},{"key":"64674_CR63","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41392-022-01296-1","volume":"8","author":"L Sui","year":"2023","unstructured":"Sui, L. et al. Host cell cycle checkpoint as antiviral target for SARS-CoV-2 revealed by integrative transcriptome and proteome analyses. Signal Transduct. Target. Ther. 8, 21 (2023).","journal-title":"Signal Transduct. Target. Ther."},{"key":"64674_CR64","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19891-7","volume":"11","author":"FS Oladunni","year":"2020","unstructured":"Oladunni, F. S. et al. Lethality of SARS-CoV-2 infection in K18 human angiotensin-converting enzyme 2 transgenic mice. Nat. Commun. 11, 6122 (2020).","journal-title":"Nat. Commun."},{"key":"64674_CR65","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00964-21","volume":"96","author":"W Dong","year":"2022","unstructured":"Dong, W. et al. The K18-human ACE2 transgenic mouse model recapitulates non-severe and severe COVID-19 in response to an infectious dose of the SARS-CoV-2 virus. J. Virol. 96, e00964-21 (2022).","journal-title":"J. Virol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-64674-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-64674-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-64674-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T01:02:58Z","timestamp":1762563778000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-64674-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,3]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["64674"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-64674-7","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,3]]},"assertion":[{"value":"12 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"X.D., W.X., J.M., M.L., K.C. and J.C. are listed as inventors on a provisional patent that relates to the methods and compounds described here. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9671"}}